Catalyst Pharmaceutical Partners Aktie
16,60
EUR
+0,06
EUR
+0,33
%
19,52
USD
+0,38
USD
+1,99
%
Werbung
Catalyst Pharmaceutical Partners Aktie Analyse
21.09.18 | Catalyst Pharmaceutical Partners Overweight | Cantor Fitzgerald | |
30.09.14 | Catalyst Pharmaceutical Partners Buy | ROTH Capital Partners, LLC | |
14.11.12 | Catalyst Pharmaceutical Partners buy | ROTH Capital Partners, LLC | |
29.11.07 | Catalyst Pharmaceutical Partners market outperform | Rodman & Renshaw |
Werbung
Werbung